Anorexia Nervosa: Root Causes, Nutritional Deficiencies & the Path to Recovery

Anorexia nervosa carries the highest mortality rate of any psychiatric disorder — a sobering fact that underscores how profoundly this condition affects the entire body, not just the mind.^[1] Yet for decades, the dominant narrative framed it almost exclusively as a psychological illness driven by distorted body image, societal pressure, and willpower. While those factors matter, they tell only part of the story.

Emerging research is revealing a far more complex picture: one in which genetic predispositions, gut-brain axis dysregulation, neuroinflammation, HPA axis dysfunction, and cascading nutritional deficiencies all converge to create — and perpetuate — the disorder. Understanding these biological root causes is not about removing personal responsibility or minimizing the psychological dimensions of anorexia. It is about building a more complete map of the terrain so that recovery can be approached with the precision and compassion it demands.

This article explores anorexia nervosa through a root-cause lens: what drives it at the biological level, how nutritional depletion deepens the cycle, and what evidence-based integrative strategies can support genuine, lasting recovery.

What Is Anorexia Nervosa? A Brief Clinical Overview

Anorexia nervosa (AN) is an eating disorder characterized by persistent restriction of energy intake, an intense fear of gaining weight, and a distorted perception of body weight or shape.^[2] The DSM-5 recognizes two subtypes: the restricting type, in which weight loss is achieved primarily through dieting, fasting, or excessive exercise; and the binge-eating/purging type, in which restriction is punctuated by episodes of bingeing or purging behaviors.

Prevalence estimates suggest that approximately 0.3–1% of women and 0.1% of men will meet diagnostic criteria for AN at some point in their lives, though subclinical presentations are considerably more common.^[3] Onset typically occurs during adolescence, though cases in children, older adults, and males are increasingly recognized. Mortality rates from medical complications and suicide are estimated at 5–10% per decade of illness.^[1]

Standard treatment approaches — cognitive behavioral therapy (CBT), family-based treatment (FBT), and nutritional rehabilitation — produce meaningful outcomes for many patients. But relapse rates remain high, hovering between 30–50% within the first year of recovery.^[4] This persistent challenge points toward biological factors that psychological interventions alone may not fully address.

The Genetic Architecture of Anorexia

Twin studies have consistently demonstrated that anorexia nervosa has a substantial heritable component, with heritability estimates ranging from 50–80%.^[5] This places AN among the most heritable psychiatric conditions — comparable to schizophrenia and bipolar disorder.

A landmark 2019 genome-wide association study (GWAS) published in Nature Genetics identified eight significant genetic loci associated with AN.^[6] Crucially, the study found that AN has significant genetic correlations not only with other psychiatric disorders (OCD, anxiety, depression, schizophrenia) but also with metabolic traits — including BMI, insulin sensitivity, and lipid metabolism. This dual psychiatric-metabolic genetic signature was a paradigm-shifting finding, suggesting that AN is not purely a mental illness but a metabo-psychiatric disorder.

Specific genes implicated include those involved in serotonin signaling (5-HTT, HTR1D), dopamine pathways (DRD4), estrogen receptor function, and appetite regulation via leptin and ghrelin systems.^[7] Variants in the EPHX2 gene — involved in cholesterol metabolism — have also been identified, reinforcing the metabolic dimension of the disorder.

The Gut-Brain Axis: A Central Driver

One of the most compelling emerging areas of anorexia research involves the gut-brain axis — the bidirectional communication network linking the enteric nervous system, the vagus nerve, the immune system, and the central nervous system via microbial metabolites, neurotransmitters, and hormonal signals.^[8]

Studies consistently show that individuals with AN have significantly altered gut microbiome compositions compared to healthy controls. Specifically, AN is associated with reduced microbial diversity, decreased populations of Lactobacillus, Bifidobacterium, and Faecalibacterium prausnitzii, increased populations of Methanobrevibacter smithii, and elevated intestinal permeability (leaky gut).^{[9][10][11][12]}

The gut microbiome also plays a direct role in serotonin production — approximately 90–95% of the body's serotonin is synthesized in the gut.^[13] Dysbiosis-driven reductions in serotonin availability may contribute to the anxiety, rigidity, and obsessive thinking that characterize AN.

For a deeper exploration, see our article on Anxiety & the Gut-Brain Axis.

Neurobiological Root Causes: Dopamine, Serotonin & Reward Processing

Serotonin (5-HT) plays a central role in mood regulation, appetite control, and behavioral flexibility. In AN, cerebrospinal fluid levels of 5-HIAA are elevated both during illness and after recovery — a pattern opposite to depression.^[16] This hyperserotonergic state is associated with increased anxiety, harm avoidance, and perfectionism — all hallmark features of AN.

Paradoxically, food restriction may temporarily reduce serotonin activity by limiting tryptophan availability, providing short-term anxiolytic relief. This creates a powerful neurochemical reinforcement loop: restricting food reduces anxiety, which reinforces restriction.^[17]

PET imaging studies show that individuals with AN have altered dopamine D2/D3 receptor binding in the striatum, blunting the rewarding properties of food while potentially amplifying the rewarding properties of restriction and control behaviors.^[18]

HPA Axis Dysfunction and Chronic Stress

The hypothalamic-pituitary-adrenal (HPA) axis is profoundly dysregulated in anorexia nervosa. Elevated cortisol levels are among the most consistent biological findings in AN, persisting even after partial weight restoration.^[21] Chronic HPA axis activation suppresses the HPG axis (causing amenorrhea and bone loss), suppresses thyroid hormone conversion, causes hippocampal atrophy, and drives immune dysregulation.^{[22][23][24][25]}

See our related articles on Adrenal Fatigue & HPA Axis Dysfunction and Chronic Stress & the Cortisol Connection.

Neuroinflammation: The Hidden Driver

Elevated levels of pro-inflammatory cytokines — including IL-6, TNF-α, and IL-1β — have been documented in AN patients even in the absence of infection or autoimmune disease.^[26] These cytokines cross the blood-brain barrier and directly alter neurotransmitter metabolism, reducing serotonin and dopamine availability while increasing glutamate activity.^[27]

For more on this mechanism, see our article on Brain Fog: Root Causes & Solutions.

The Nutritional Deficiency Cascade

Severe caloric restriction in AN produces a predictable cascade of micronutrient deficiencies — each compounding the neurological, hormonal, and psychological dysfunction driving the disorder.

Zinc

Zinc deficiency is one of the most clinically significant findings in AN.^[29] A landmark RCT by Katz et al. (1987) found that zinc supplementation significantly accelerated weight gain in hospitalized AN patients compared to placebo.^[30]

B Vitamins and Methylation

Thiamine (B1) deficiency is a medical emergency in refeeding syndrome, capable of causing Wernicke's encephalopathy.^[32] B6 and folate are essential cofactors in serotonin and dopamine synthesis.^[33] Methylation impairment driven by folate and B12 deficiency disrupts DNA repair and elevates homocysteine.^[35] See our article on B Vitamins & Methylation.

Iron, Magnesium, Vitamin D & Omega-3s

Iron deficiency anemia is common in AN, compounding neurotransmitter dysregulation.^[36] Magnesium deficiency contributes to cardiac arrhythmias, anxiety, and insomnia, and is a key risk factor in refeeding syndrome.^[37] Vitamin D deficiency is nearly universal in AN and functions as a neurosteroid modulating serotonin synthesis.^[38] Omega-3 depletion impairs neuronal membrane fluidity and worsens depression and cognitive function.^[39][40]

Electrolytes

Hypokalemia, hypophosphatemia, and hyponatremia are the primary drivers of cardiac arrhythmias and sudden death in AN.^[41] Hypophosphatemia is the hallmark of refeeding syndrome and requires careful monitoring.

Bone Health, Cardiovascular Complications & Refeeding Syndrome

Osteopenia and osteoporosis affect up to 85% of patients with chronic AN.^[42] Bone loss is driven by estrogen deficiency, elevated cortisol, IGF-1 deficiency, and calcium/vitamin D deficiency — and is not fully reversible with weight restoration alone.^[43]

Cardiac complications are the leading cause of medical mortality in AN, including bradycardia, QTc prolongation, mitral valve prolapse, and pericardial effusion.^[44][45]

Refeeding syndrome is a potentially life-threatening complication when nutrition is reintroduced too rapidly. Prevention requires a slow, monitored protocol beginning at 10–20 kcal/kg/day with prophylactic thiamine, phosphate, potassium, and magnesium supplementation.^[46][47]

Psychological and Trauma-Related Root Causes

Adverse childhood experiences (ACEs) are significantly more prevalent in individuals with eating disorders than in the general population.^[48] Trauma dysregulates the HPA axis, alters gut microbiome composition, impairs interoceptive awareness, and shapes neural circuits governing reward and emotional regulation.

Perfectionism, harm avoidance, and obsessive-compulsive traits are among the most robust psychological risk factors for AN.^[49] These reflect underlying neurobiological patterns in serotonin signaling and prefrontal-limbic connectivity.

Integrative and Nutritional Recovery Strategies

1. Gradual, Supervised Nutritional Rehabilitation — Weight restoration is the foundational priority. Nutritional rehabilitation should be gradual, individualized, and medically supervised with careful attention to refeeding syndrome prevention.

2. Targeted Micronutrient Repletion — Systematic correction of deficiencies in zinc, B vitamins (especially thiamine), iron, magnesium, vitamin D, and omega-3 fatty acids should be guided by laboratory testing.

3. Gut Microbiome Restoration — Probiotic supplementation (particularly Lactobacillus and Bifidobacterium strains) and prebiotic fiber may help restore gut-brain axis signaling and improve serotonin availability.^[50]

4. Anti-Inflammatory Nutritional Support — Omega-3 fatty acids (EPA + DHA), curcumin, and magnesium support brain recovery and emotional regulation. See our Anti-Inflammatory Lifestyle article.

5. HPA Axis Support — Adaptogenic herbs including ashwagandha and rhodiola have demonstrated efficacy in reducing cortisol reactivity.^[51]

6. Trauma-Informed Psychotherapy — EMDR, somatic experiencing, and trauma-focused CBT address the neurobiological imprints of early adversity contributing to HPA axis dysregulation.

7. Nervous System Regulation — Diaphragmatic breathing, yoga, and mindfulness meditation activate the parasympathetic nervous system and support interoceptive awareness.^[52]

8. Bone Health Optimization — Calcium (1000–1500 mg/day), vitamin D3 (2000–5000 IU/day), vitamin K2 (MK-7), and magnesium should be initiated early and maintained throughout recovery.

When to Seek Medical Care

Anorexia nervosa is a medical emergency when BMI is below 15, with rapid weight loss, cardiac arrhythmias, syncope, or severe electrolyte abnormalities. Inpatient stabilization should not be delayed.

If you or someone you know is struggling with an eating disorder, please contact the National Eating Disorders Association (NEDA) Helpline at 1-800-931-2237, or text "NEDA" to 741741.

Conclusion

Anorexia nervosa sits at the intersection of genetics, neurobiology, gut health, hormonal regulation, nutritional biochemistry, and psychological experience. Understanding it through a root-cause lens enriches our capacity to address it with precision and compassion. The biological factors explored here — gut-brain axis dysregulation, serotonin and dopamine imbalances, HPA axis hyperactivation, neuroinflammation, and cascading micronutrient deficiencies — are central drivers that shape the experience of the disorder and the trajectory of recovery.

Recovery is possible. And the more completely we understand the terrain, the more effectively we can navigate it.

References

1. Arcelus J, et al. (2011). Archives of General Psychiatry, 68(7), 724–731.
2. American Psychiatric Association. (2013). DSM-5.
3. Hoek HW. (2006). Current Opinion in Psychiatry, 19(4), 389–394.
4. Khalsa SS, et al. (2017). Psychiatric Clinics of North America, 40(2), 287–299.
5. Bulik CM, et al. (2006). American Journal of Psychiatry, 163(9), 1549–1554.
6. Watson HJ, et al. (2019). Nature Genetics, 51(8), 1207–1214.
7. Gorwood P, et al. (2003). American Journal of Psychiatry, 160(5), 948–959.
8. Cryan JF, et al. (2019). Physiological Reviews, 99(4), 1877–2013.
9. Kleiman SC, et al. (2015). Psychosomatic Medicine, 77(9), 969–981.
10. Borgo F, et al. (2017). PLOS ONE, 12(6), e0179739.
11. Morita C, et al. (2015). PLOS ONE, 10(12), e0145274.
12. Mörkl S, et al. (2018). International Journal of Eating Disorders, 50(12), 1421–1431.
13. Yano JM, et al. (2015). Cell, 161(2), 264–276.
14. Germain N, et al. (2007). Nutrition & Metabolism, 4, 5.
15. Frank GKW. (2015). European Eating Disorders Review, 23(5), 331–341.
16. Kaye WH, et al. (1991). Archives of General Psychiatry, 48(6), 556–562.
17. Kaye WH, et al. (2005). Nature Reviews Neuroscience, 6(8), 634–640.
18. Frank GKW, et al. (2005). American Journal of Psychiatry, 162(6), 1152–1161.
19. Casper RC. (1998). International Journal of Eating Disorders, 24(4), 381–393.
20. Nunn K, et al. (2008). European Eating Disorders Review, 16(5), 355–360.
21. Lawson EA, et al. (2011). European Journal of Endocrinology, 164(2), 253–261.
22. Misra M, Klibanski A. (2014). The Lancet Diabetes & Endocrinology, 2(7), 581–592.
23. Rosenbaum M, Leibel RL. (2014). International Journal of Obesity, 34(S1), S47–S55.
24. Sapolsky RM. (2000). Archives of General Psychiatry, 57(10), 925–935.
25. Solmi M, et al. (2018). Psychoneuroendocrinology, 51, 237–252.
26. Himmerich H, et al. (2019). Frontiers in Psychiatry, 10, 30.
27. Miller AH, Raison CL. (2016). Nature Reviews Immunology, 16(1), 22–34.
28. Fetissov SO, Déchelotte P. (2011). Current Opinion in Clinical Nutrition & Metabolic Care, 14(5), 477–482.
29. Katz RL, et al. (1987). Journal of Adolescent Health Care, 8(5), 400–406.
30. Birmingham CL, Gritzner S. (2006). Eating and Weight Disorders, 11(4), e109–e111.
31. Winston AP. (2012). Annals of Clinical Biochemistry, 49(2), 132–143.
32. Sechi G, Serra A. (2007). The Lancet Neurology, 6(5), 442–455.
33. Young SN. (2007). Journal of Psychiatry & Neuroscience, 32(6), 394–399.
34. Stabler SP. (2013). New England Journal of Medicine, 368(2), 149–160.
35. Selhub J. (1999). Annual Review of Nutrition, 19, 217–246.
36. Caregaro L, et al. (2001). Nutrition, 17(11–12), 952–959.
37. Mehler PS, Cleary BS, Gaudiani JL. (2011). Eating Disorders, 19(2), 194–202.
38. Misra M, Klibanski A. (2011). Current Opinion in Endocrinology, Diabetes and Obesity, 18(6), 376–382.
39. Simopoulos AP. (2002). Journal of the American College of Nutrition, 21(6), 495–505.
40. Ayton AK, et al. (2004). Nutritional Neuroscience, 7(1), 1–12.
41. Mehler PS, et al. (2010). The American Journal of Medicine, 123(6), 491–498.
42. Mehler PS, MacKenzie TD. (2009). International Journal of Eating Disorders, 42(1), 70–76.
43. Misra M, et al. (2004). Pediatrics, 114(6), 1574–1583.
44. Casiero D, Frishman WH. (2006). Cardiology in Review, 14(5), 227–231.
45. Cooke RA, et al. (1994). British Heart Journal, 72(1), 69–73.
46. Mehanna HM, Moledina J, Travis J. (2008). BMJ, 336(7659), 1495–1498.
47. NICE. (2017). Eating disorders: recognition and treatment. NG69.
48. Racine SE, Wildes JE. (2015). International Journal of Eating Disorders, 48(1), 55–58.
49. Lilenfeld LR, et al. (2006). Clinical Psychology Review, 26(3), 299–320.
50. Kleiman SC, et al. (2015). Psychosomatic Medicine, 77(9), 969–981.
51. Pratte MA, et al. (2014). Journal of Alternative and Complementary Medicine, 20(12), 901–908.
52. Streeter CC, et al. (2012). Medical Hypotheses, 78(5), 571–579.